Abstract | BACKGROUND & AIMS: METHODS: We performed an open-labeled study of a ω-3 PUFAs based ILE in 15 adults with SBS who developed cholestasis while receiving soybean oil-based ILE. Liver biopsies were performed before and after the initiation of ω-3 PUFAs to confirm the presence and improvement of cholestasis. Blood samples were collected every week for analysis of fatty acid composition and liver function. RESULTS: 12 of the 15 patients had their direct bilirubin normalized within 4 weeks and our data demonstrated a significant decrease in both DB (P ≤ 0.001) and TB (P ≤ 0.001) after 4 weeks compared to baseline. There were ameliorations of liver function and fatty acid patterns in all patients and serial liver biopsy specimens showed progressive histologic improvement. CONCLUSIONS: Parenteral ω-3 PUFAs supplemented fat emulsions are safe and effective in the treatment of PNALD in adults.
|
Authors | Ziwei Xu, Yousheng Li, Jian Wang, Bo Wu, Jieshou Li |
Journal | Clinical nutrition (Edinburgh, Scotland)
(Clin Nutr)
Vol. 31
Issue 2
Pg. 217-23
(Apr 2012)
ISSN: 1532-1983 [Electronic] England |
PMID | 22035955
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved. |
Chemical References |
- Fat Emulsions, Intravenous
- Fatty Acids, Omega-3
- Fish Oils
- Soybean Oil
- Bilirubin
|
Topics |
- Adult
- Bilirubin
(blood)
- Biopsy
- Cholestasis
(complications, drug therapy)
- Fat Emulsions, Intravenous
(administration & dosage)
- Fatty Acids, Omega-3
(administration & dosage)
- Female
- Fish Oils
(administration & dosage)
- Humans
- Liver
(pathology)
- Liver Diseases
(complications, drug therapy)
- Liver Function Tests
- Male
- Middle Aged
- Parenteral Nutrition
(adverse effects)
- Short Bowel Syndrome
(complications, drug therapy)
- Soybean Oil
(administration & dosage)
- Treatment Outcome
- Young Adult
|